IMCD NV (XAMS:IMCD) Quality Rank


XAMS:IMCD IMCD NV XAMS:IMCD
86 GF Score
Price €83.16
GF Value €141.47
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is IMCD NV Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

IMCD NV Quality Rank Related Terms

XAMS:IMCD
86GF Score
IMCD NV XAMS:IMCD
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is IMCD NV (XAMS:IMCD) Overvalued in 2026?

Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued. The current stock price of €83.16 is trading 41.2% below its estimated GF Value™ of €141.47. GuruFocus considers IMCD NV to be Significantly Undervalued.

Key valuation signals for XAMS:IMCD:

  • Quality Rank:
  • GF Value™: €141.47 vs. price of €83.16 (41.2% below fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the XAMS:IMCD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

IMCD NV Business Description

Address Wilhelminaplein 32, Rotterdam, NLD, 3072 DE
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
86GF Score

Get the complete analysis for XAMS:IMCD

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€83.16
Price
€141.47
GF Value